ERBB2 and ductal breast carcinoma in situ: It was reported that the distribution of molecular subtypes differed among DCIS, DCISM, and invasive ductal carcinoma (IDC) entity,12 of which the HER2 positivity and HR negativity were associated with higher nuclear grade and poorer survival in MIBC, respectively.10, 13